Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2026-01-21 @ 6:33 AM
Study NCT ID:
NCT02237261
Status:
COMPLETED
Last Update Posted:
2020-10-19
First Post:
2014-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
Sponsor:
University Hospital Heidelberg
Organization: